Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022

Upgrades

Stifel upgraded the previous rating for Revolution Medicines Inc RVMD from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71, compared to year-ago quarter EPS of $0.52. The stock has a 52-week-high of $50.88 and a 52-week-low of $18.07. At the end of the last trading period, Revolution Medicines closed at $18.92.

According to UBS, the prior rating for Amedisys Inc AMED was changed from Sell to Neutral. For the fourth quarter, Amedisys had an EPS of $1.18, compared to year-ago quarter EPS of $1.49. At the moment, the stock has a 52-week-high of $292.97 and a 52-week-low of $122.12. Amedisys closed at $160.24 at the end of the last trading period.

For Sunstone Hotel Investors Inc SHO, Evercore ISI Group upgraded the previous rating of In-Line to Outperform. At the moment, the stock has a 52-week-high of $13.91 and a 52-week-low of $9.93. Sunstone Hotel Invts closed at $10.58 at the end of the last trading period.

Wedbush upgraded the previous rating for Logitech International SA LOGI from Neutral to Outperform. In the third quarter, Logitech International showed an EPS of $1.55, compared to $2.45 from the year-ago quarter. The stock has a 52-week-high of $140.17 and a 52-week-low of $69.92. At the end of the last trading period, Logitech International closed at $74.64.

For Farfetch Ltd FTCH, Societe Generale upgraded the previous rating of Sell to Hold. Farfetch earned $0.03 in the fourth quarter, compared to $0.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $67.71 and a 52-week-low of $12.36. Farfetch closed at $19.05 at the end of the last trading period.

According to B. Riley Securities, the prior rating for Quanta Services Inc PWR was changed from Neutral to Buy. In the fourth quarter, Quanta Servs showed an EPS of $1.54, compared to $1.22 from the year-ago quarter. The current stock performance of Quanta Servs shows a 52-week-high of $124.69 and a 52-week-low of $78.79. Moreover, at the end of the last trading period, the closing price was at $108.94.

For Jack Henry & Associates Inc JKHY, Oppenheimer upgraded the previous rating of Perform to Outperform. Jack Henry & Associates earned $1.30 in the second quarter, compared to $0.92 in the year-ago quarter. The stock has a 52-week-high of $179.98 and a 52-week-low of $146.10. At the end of the last trading period, Jack Henry & Associates closed at $176.80.

For Lennox International Inc LII, Morgan Stanley upgraded the previous rating of Underweight to Equal-Weight. Lennox International earned $2.35 in the fourth quarter, compared to $2.89 in the year-ago quarter. At the moment, the stock has a 52-week-high of $356.36 and a 52-week-low of $243.92. Lennox International closed at $266.93 at the end of the last trading period.

For Advanced Drainage Systems Inc WMS, Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, Advanced Drainage Systems showed an EPS of $0.86, compared to $0.62 from the year-ago quarter. At the moment, the stock has a 52-week-high of $138.02 and a 52-week-low of $93.66. Advanced Drainage Systems closed at $116.72 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

According to Tudor Pickering, the prior rating for Cactus Inc WHD was changed from Buy to Hold. For the fourth quarter, Cactus had an EPS of $0.25, compared to year-ago quarter EPS of $0.08. The stock has a 52-week-high of $51.51 and a 52-week-low of $27.26. At the end of the last trading period, Cactus closed at $50.66.

According to Janney Montgomery Scott, the prior rating for First Horizon Corp FHN was changed from Buy to Neutral. First Horizon earned $0.48 in the fourth quarter, compared to $0.46 in the year-ago quarter. The current stock performance of First Horizon shows a 52-week-high of $24.24 and a 52-week-low of $14.67. Moreover, at the end of the last trading period, the closing price was at $23.48.

According to Craig-Hallum, the prior rating for Velodyne Lidar Inc VLDR was changed from Hold to Sell. In the fourth quarter, Velodyne Lidar showed an EPS of $0.16, compared to $0.12 from the year-ago quarter. The stock has a 52-week-high of $17.20 and a 52-week-low of $3.13. At the end of the last trading period, Velodyne Lidar closed at $3.69.

According to Truist Securities, the prior rating for Comcast Corp CMCSA was changed from Buy to Hold. Comcast earned $0.77 in the fourth quarter, compared to $0.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of $61.80 and a 52-week-low of $44.27. Comcast closed at $46.76 at the end of the last trading period.

For Voya Financial Inc VOYA, Piper Sandler downgraded the previous rating of Overweight to Neutral. In the fourth quarter, Voya Financial showed an EPS of $1.90, compared to $1.44 from the year-ago quarter. The stock has a 52-week-high of $74.97 and a 52-week-low of $58.97. At the end of the last trading period, Voya Financial closed at $67.35.

According to Piper Sandler, the prior rating for Ameriprise Financial Inc AMP was changed from Overweight to Neutral. In the fourth quarter, Ameriprise Financial showed an EPS of $6.15, compared to $4.53 from the year-ago quarter. The current stock performance of Ameriprise Financial shows a 52-week-high of $332.37 and a 52-week-low of $213.38. Moreover, at the end of the last trading period, the closing price was at $299.79.

For Charter Communications Inc CHTR, Truist Securities downgraded the previous rating of Buy to Hold. In the fourth quarter, Charter Communications showed an EPS of $8.93, compared to $6.05 from the year-ago quarter. At the moment, the stock has a 52-week-high of $825.62 and a 52-week-low of $549.59. Charter Communications closed at $601.78 at the end of the last trading period.

According to Stifel, the prior rating for Pennant Group Inc PNTG was changed from Buy to Hold. In the fourth quarter, Pennant Group showed an EPS of $0.07, compared to $0.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of $58.21 and a 52-week-low of $12.94. Pennant Group closed at $16.25 at the end of the last trading period.

According to William Blair, the prior rating for ON24 Inc ONTF was changed from Outperform to Market Perform. For the fourth quarter, ON24 had an EPS of $0.03, compared to year-ago quarter EPS of $0.57. At the moment, the stock has a 52-week-high of $64.50 and a 52-week-low of $14.03. ON24 closed at $15.60 at the end of the last trading period.

Cowen & Co. downgraded the previous rating for GoodRx Holdings Inc GDRX from Outperform to Market Perform. For the fourth quarter, GoodRx Holdings had an EPS of $0.09, compared to year-ago quarter EPS of $0.08. The stock has a 52-week-high of $48.05 and a 52-week-low of $21.13. At the end of the last trading period, GoodRx Holdings closed at $27.40.

For Turtle Beach Corp HEAR, Wedbush downgraded the previous rating of Outperform to Neutral. For the third quarter, Turtle Beach had an EPS of $0.26, compared to year-ago quarter EPS of $1.05. The stock has a 52-week-high of $38.70 and a 52-week-low of $17.03. At the end of the last trading period, Turtle Beach closed at $23.77.

B of A Securities downgraded the previous rating for Viatris Inc VTRS from Buy to Neutral. In the fourth quarter, Viatris showed an EPS of $0.80, compared to $1.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $16.29 and a 52-week-low of $10.88. Viatris closed at $11.01 at the end of the last trading period.

According to Raymond James, the prior rating for Viatris Inc VTRS was changed from Outperform to Market Perform. Viatris earned $0.80 in the fourth quarter, compared to $1.07 in the year-ago quarter. The stock has a 52-week-high of $16.29 and a 52-week-low of $10.88. At the end of the last trading period, Viatris closed at $11.01.

For Sunstone Hotel Investors Inc SHO, Barclays downgraded the previous rating of Overweight to Underweight. The stock has a 52-week-high of $13.91 and a 52-week-low of $9.93. At the end of the last trading period, Sunstone Hotel Invts closed at $10.58.

For Foot Locker Inc FL, Barclays downgraded the previous rating of Overweight to Underweight. In the fourth quarter, Foot Locker showed an EPS of $1.67, compared to $1.55 from the year-ago quarter. The current stock performance of Foot Locker shows a 52-week-high of $66.71 and a 52-week-low of $26.36. Moreover, at the end of the last trading period, the closing price was at $31.62.

According to Citigroup, the prior rating for Meritor Inc MTOR was changed from Buy to Neutral. For the first quarter, Meritor had an EPS of $0.80, compared to year-ago quarter EPS of $0.60. At the moment, the stock has a 52-week-high of $36.24 and a 52-week-low of $20.50. Meritor closed at $35.61 at the end of the last trading period.

Citigroup downgraded the previous rating for BP Midstream Partners LP BPMP from Neutral to Sell. In the third quarter, BP Midstream Partners showed an EPS of $0.27, compared to $0.42 from the year-ago quarter. The current stock performance of BP Midstream Partners shows a 52-week-high of $19.37 and a 52-week-low of $11.01. Moreover, at the end of the last trading period, the closing price was at $16.63.

Wells Fargo downgraded the previous rating for Vroom Inc VRM from Overweight to Equal-Weight. In the fourth quarter, Vroom showed an EPS of $0.94, compared to $0.44 from the year-ago quarter. The current stock performance of Vroom shows a 52-week-high of $49.03 and a 52-week-low of $5.10. Moreover, at the end of the last trading period, the closing price was at $6.08.

B. Riley Securities downgraded the previous rating for Foot Locker Inc FL from Buy to Neutral. In the fourth quarter, Foot Locker showed an EPS of $1.67, compared to $1.55 from the year-ago quarter. The current stock performance of Foot Locker shows a 52-week-high of $66.71 and a 52-week-low of $26.36. Moreover, at the end of the last trading period, the closing price was at $31.62.

Raymond James downgraded the previous rating for First Horizon Corp FHN from Outperform to Market Perform. First Horizon earned $0.48 in the fourth quarter, compared to $0.46 in the year-ago quarter. At the moment, the stock has a 52-week-high of $24.24 and a 52-week-low of $14.67. First Horizon closed at $23.48 at the end of the last trading period.

For Gemini Therapeutics Inc GMTX, Jefferies downgraded the previous rating of Buy to Hold. The stock has a 52-week-high of $19.09 and a 52-week-low of $1.36. At the end of the last trading period, Gemini Therapeutics closed at $1.36.

Credit Suisse downgraded the previous rating for GoodRx Holdings Inc GDRX from Outperform to Neutral. For the fourth quarter, GoodRx Holdings had an EPS of $0.09, compared to year-ago quarter EPS of $0.08. The stock has a 52-week-high of $48.05 and a 52-week-low of $21.13. At the end of the last trading period, GoodRx Holdings closed at $27.40.

Baird downgraded the previous rating for ON24 Inc ONTF from Outperform to Neutral. In the fourth quarter, ON24 showed an EPS of $0.03, compared to $0.57 from the year-ago quarter. The stock has a 52-week-high of $64.50 and a 52-week-low of $14.03. At the end of the last trading period, ON24 closed at $15.60.

For Wix.com Ltd WIX, Atlantic Equities downgraded the previous rating of Overweight to Neutral. In the fourth quarter, Wix.com showed an EPS of $0.37, compared to $0.03 from the year-ago quarter. At the moment, the stock has a 52-week-high of $361.62 and a 52-week-low of $77.64. Wix.com closed at $91.58 at the end of the last trading period.

Piper Sandler downgraded the previous rating for ON24 Inc ONTF from Overweight to Neutral. ON24 earned $0.03 in the fourth quarter, compared to $0.57 in the year-ago quarter. The stock has a 52-week-high of $64.50 and a 52-week-low of $14.03. At the end of the last trading period, ON24 closed at $15.60.

Goldman Sachs downgraded the previous rating for Lincoln National Corp LNC from Buy to Neutral. For the fourth quarter, Lincoln National had an EPS of $1.56, compared to year-ago quarter EPS of $1.78. The current stock performance of Lincoln National shows a 52-week-high of $77.57 and a 52-week-low of $55.01. Moreover, at the end of the last trading period, the closing price was at $67.42.

For Foot Locker Inc FL, Goldman Sachs downgraded the previous rating of Buy to Neutral. In the fourth quarter, Foot Locker showed an EPS of $1.67, compared to $1.55 from the year-ago quarter. The stock has a 52-week-high of $66.71 and a 52-week-low of $26.36. At the end of the last trading period, Foot Locker closed at $31.62.

See all analyst ratings downgrades.

Initiations

Guggenheim initiated coverage on Ionis Pharmaceuticals Inc IONS with a Buy rating. The price target for Ionis Pharmaceuticals is set to $64.00. For the fourth quarter, Ionis Pharmaceuticals had an EPS of $1.55, compared to year-ago quarter EPS of $0.81. The stock has a 52-week-high of $56.01 and a 52-week-low of $25.04. At the end of the last trading period, Ionis Pharmaceuticals closed at $33.38.

With an Overweight rating, Piper Sandler initiated coverage on Silver Spike Investment Corp SSIC. The price target seems to have been set at $17.00 for Silver Spike Inv. The current stock performance of Silver Spike Inv shows a 52-week-high of $15.40 and a 52-week-low of $13.30. Moreover, at the end of the last trading period, the closing price was at $14.17.

With an Outperform rating, SVB Leerink initiated coverage on Arcellx Inc ACLX. The price target seems to have been set at $47.00 for Arcellx. The current stock performance of Arcellx shows a 52-week-high of $19.93 and a 52-week-low of $15.55. Moreover, at the end of the last trading period, the closing price was at $19.14.

With a Buy rating, Needham initiated coverage on ACV Auctions Inc ACVA. The price target seems to have been set at $20.00 for ACV Auctions. At the moment, the stock has a 52-week-high of $37.77 and a 52-week-low of $10.30. ACV Auctions closed at $13.19 at the end of the last trading period.

With a Buy rating, Ladenburg Thalmann initiated coverage on Onconova Therapeutics Inc ONTX. The price target seems to have been set at $7.00 for Onconova Therapeutics. Onconova Therapeutics earned $0.22 in the third quarter, compared to $0.45 in the year-ago quarter. The current stock performance of Onconova Therapeutics shows a 52-week-high of $10.84 and a 52-week-low of $0.49. Moreover, at the end of the last trading period, the closing price was at $1.62.

With a Buy rating, Ladenburg Thalmann initiated coverage on NextCure Inc NXTC. The price target seems to have been set at $16.00 for NextCure. For the third quarter, NextCure had an EPS of $0.65, compared to year-ago quarter EPS of $0.59. The stock has a 52-week-high of $12.98 and a 52-week-low of $4.63. At the end of the last trading period, NextCure closed at $4.90.

B of A Securities initiated coverage on Arcellx Inc ACLX with a Buy rating. The price target for Arcellx is set to $24.00. The current stock performance of Arcellx shows a 52-week-high of $19.93 and a 52-week-low of $15.55. Moreover, at the end of the last trading period, the closing price was at $19.14.

Benchmark initiated coverage on Pinterest Inc PINS with a Hold rating. For the fourth quarter, Pinterest had an EPS of $0.49, compared to year-ago quarter EPS of $0.43. At the moment, the stock has a 52-week-high of $88.83 and a 52-week-low of $22.31. Pinterest closed at $26.75 at the end of the last trading period.

Benchmark initiated coverage on Twitter Inc TWTR with a Hold rating. For the fourth quarter, Twitter had an EPS of $0.33, compared to year-ago quarter EPS of $0.38. The stock has a 52-week-high of $79.08 and a 52-week-low of $31.30. At the end of the last trading period, Twitter closed at $35.55.

Benchmark initiated coverage on Snap Inc SNAP with a Buy rating. The price target for Snap is set to $50.00. For the fourth quarter, Snap had an EPS of $0.22, compared to year-ago quarter EPS of $0.09. The current stock performance of Snap shows a 52-week-high of $83.34 and a 52-week-low of $24.32. Moreover, at the end of the last trading period, the closing price was at $39.94.

For The Trade Desk Inc TTD, Benchmark initiated coverage, by setting the current rating at Hold. Trade Desk earned $0.42 in the fourth quarter, compared to $0.37 in the year-ago quarter. The current stock performance of Trade Desk shows a 52-week-high of $835.00 and a 52-week-low of $55.05. Moreover, at the end of the last trading period, the closing price was at $85.32.

Benchmark initiated coverage on Criteo SA CRTO with a Buy rating. The price target for Criteo is set to $45.00. Criteo earned $1.44 in the fourth quarter, compared to $0.98 in the year-ago quarter. The stock has a 52-week-high of $46.65 and a 52-week-low of $29.30. At the end of the last trading period, Criteo closed at $33.26.

For Meta Platforms Inc FB, Benchmark initiated coverage, by setting the current rating at Hold. In the fourth quarter, Meta Platforms showed an EPS of $3.67, compared to $3.88 from the year-ago quarter. The stock has a 52-week-high of $384.33 and a 52-week-low of $190.22. At the end of the last trading period, Meta Platforms closed at $211.03.

Wells Fargo initiated coverage on Taysha Gene Therapies Inc TSHA with an Overweight rating. The price target for Taysha Gene Therapies is set to $25.00. Taysha Gene Therapies earned $1.35 in the third quarter, compared to $1.28 in the year-ago quarter. The current stock performance of Taysha Gene Therapies shows a 52-week-high of $29.90 and a 52-week-low of $5.57. Moreover, at the end of the last trading period, the closing price was at $6.37.

RBC Capital initiated coverage on MongoDB Inc MDB with an Outperform rating. The price target for MongoDB is set to $505.00. In the third quarter, MongoDB showed an EPS of $0.11, compared to $0.31 from the year-ago quarter. The current stock performance of MongoDB shows a 52-week-high of $590.00 and a 52-week-low of $238.01. Moreover, at the end of the last trading period, the closing price was at $381.99.

JMP Securities initiated coverage on America First Multifamily Investors LP ATAX with a Market Outperform rating. The price target for America First Multifamily is set to $7.00. America First Multifamily earned $0.11 in the fourth quarter, compared to $0.00 in the year-ago quarter. At the moment, the stock has a 52-week-high of $7.11 and a 52-week-low of $4.56. America First Multifamily closed at $6.48 at the end of the last trading period.

Citigroup initiated coverage on Alnylam Pharmaceuticals Inc ALNY with a Buy rating. The price target for Alnylam Pharmaceuticals is set to $223.00. Alnylam Pharmaceuticals earned $1.69 in the fourth quarter, compared to $1.60 in the year-ago quarter. At the moment, the stock has a 52-week-high of $212.00 and a 52-week-low of $125.00. Alnylam Pharmaceuticals closed at $157.85 at the end of the last trading period.

Stifel initiated coverage on Silver Spike Investment Corp SSIC with a Hold rating. The current stock performance of Silver Spike Inv shows a 52-week-high of $15.40 and a 52-week-low of $13.30. Moreover, at the end of the last trading period, the closing price was at $14.17.

Mizuho initiated coverage on Constellation Energy Corp CEG with a Neutral rating. The price target for Constellation Energy is set to $46.00. The stock has a 52-week-high of $56.57 and a 52-week-low of $42.18. At the end of the last trading period, Constellation Energy closed at $45.98.

Citigroup initiated coverage on Schrodinger Inc SDGR with a Buy rating. The price target for Schrodinger is set to $55.00. In the fourth quarter, Schrodinger showed an EPS of $0.43, compared to $0.18 from the year-ago quarter. The current stock performance of Schrodinger shows a 52-week-high of $114.10 and a 52-week-low of $23.14. Moreover, at the end of the last trading period, the closing price was at $34.76.

Citigroup initiated coverage on Ionis Pharmaceuticals Inc IONS with a Sell rating. The price target for Ionis Pharmaceuticals is set to $26.00. For the fourth quarter, Ionis Pharmaceuticals had an EPS of $1.55, compared to year-ago quarter EPS of $0.81. The stock has a 52-week-high of $56.01 and a 52-week-low of $25.04. At the end of the last trading period, Ionis Pharmaceuticals closed at $33.38.

Citigroup initiated coverage on Blueprint Medicines Corp BPMC with a Neutral rating. Blueprint Medicines earned $0.99 in the fourth quarter, compared to $1.53 in the year-ago quarter. At the moment, the stock has a 52-week-high of $117.86 and a 52-week-low of $60.12. Blueprint Medicines closed at $60.55 at the end of the last trading period.

Citigroup initiated coverage on Ascendis Pharma A/S ASND with a Buy rating. The price target for Ascendis Pharma is set to $187.00. For the third quarter, Ascendis Pharma had an EPS of $1.73, compared to year-ago quarter EPS of $2.70. The stock has a 52-week-high of $178.71 and a 52-week-low of $103.81. At the end of the last trading period, Ascendis Pharma closed at $112.39.

See all analyst ratings initiations.